1. Pain and Policy Studies Group (University of Wisconsin-Madison). Global Opioid Consumption, 2011. Available at:
http://www.painpolicy.wisc.edu
/country/profile/canada (Accessed December 4, 2015).
2. Reitsma M, Tranmer J, Buchanan D, Vandenkerkhof E. The prevalence of chronic pain and pain-related interference in the Canadian population from 1994 to 2008. Chronic Dis Inj Can 2011;31(4):157–64. PMID: 21978639.
3. Gomes T, Paterson JM, Caetano P, Sketris I, Henry D. Canadian Network for Observational Drug Effect Studies. Part 1: Changes in the dispensing of oral opioid drugs in Canadian provinces between 2008 and the end of 2013. Unpublished report. Montreal, QC: Canadian Network for Observational Drug Effect Studies, 2015.
4. Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: A systematic review for a National Institutes of Health pathways to prevention workshop. Ann Intern Med 2015;162(4):276–86. PMID: 25581257. doi: 10.7326/M14-2559.
5. Braden J, Russo J, Fan M, Edlund MJ, Martin BC, DeVries A, et al. Emergency department visits among recipients of chronic opioid therapy. Arch Intern Med 2010;170(16):1425–32. PMID: 20837827. doi: 10.1001/archinternmed.2010.273.